SCHEMBL14770610

SCHEMBL14770610

c1ccc2c(c1)c1ccccc1n2-c1ccc(-c2ccc3oc4ccc(-n5c6ccccc6c6ccccc65)cc4c3c2)nc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
P2RX3 P56373 4/20 0.32
P2RX2 Q9UBL9 4/20 0.32
NPC1 O15118 2/20 0.32
MAPT P10636 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
RAB9A P51151 1/20 0.32
KMT2A Q03164 1/20 0.32
CHEK2 O96017 1/20 0.31
CASP3 P42574 1/20 0.31
SENP7 Q9BQF6 1/20 0.31
SENP6 Q9GZR1 1/20 0.31
PTPRF P10586 3/20 0.31
PTPN2 P17706 3/20 0.31
PTPN1 P18031 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18158871 0.88 KDM4E (0.40) KDM4EATML3MBTL1P2RX3P2RX2
SCHEMBL12153438 0.87 KDM4E (0.40) KDM4EATML3MBTL1P2RX3P2RX2
SCHEMBL20097829 0.85 NPY5R (0.40) KDM4EATML3MBTL1NPC1MAPT
SCHEMBL280420 0.85 KDM4E (0.46) KDM4EATML3MBTL1NPC1MAPT
SCHEMBL2628401 0.85 KDM4E (0.46) KDM4EATML3MBTL1NPC1MAPT
SCHEMBL15780991 0.85 KDM4E (0.46) KDM4EATML3MBTL1NPC1MAPT
SCHEMBL14770703 0.85 KDM4E (0.36) KDM4EATML3MBTL1NPC1MAPT
SCHEMBL10041340 0.84 KDM4E (0.38) KDM4EATML3MBTL1NPC1MAPT
SCHEMBL12153500 0.84 KDM4E (0.42) KDM4EATML3MBTL1P2RX3P2RX2
SCHEMBL10041344 0.84 KDM4E (0.35) KDM4EATML3MBTL1NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9604972-B2 Nitrogen-containing heteroaromatic ring compound IDEMITSU KOSAN CO., LTD. (JP) 2017-03-28 US disclosed
US-9604972-B2 Nitrogen-containing heteroaromatic ring compound IDEMITSU KOSAN CO., LTD. (JP) 2017-03-28 US disclosed
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-03-14 US disclosed
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND TDO2, AHR, NOC2L KDM4E 1763/4885ATM 1105/4885L3MBTL1 3163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.